IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 70 filers reported holding IRADIMED CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267 | +7.7% | 6,025 | +15.9% | 0.00% | – |
| Q2 2023 | $248 | +25.3% | 5,198 | +2.8% | 0.00% | – |
| Q1 2023 | $198 | +23.0% | 5,055 | -11.2% | 0.00% | – |
| Q4 2022 | $161 | -99.9% | 5,692 | +0.2% | 0.00% | – |
| Q3 2022 | $170,000 | -12.4% | 5,680 | -0.8% | 0.00% | – |
| Q2 2022 | $194,000 | +104.2% | 5,724 | +168.6% | 0.00% | – |
| Q1 2022 | $95,000 | 0.0% | 2,131 | +3.3% | 0.00% | – |
| Q4 2021 | $95,000 | +295.8% | 2,063 | +150.4% | 0.00% | – |
| Q2 2021 | $24,000 | +71.4% | 824 | +27.0% | 0.00% | – |
| Q4 2020 | $14,000 | -17.6% | 649 | -18.9% | 0.00% | – |
| Q3 2020 | $17,000 | -59.5% | 800 | -55.9% | 0.00% | – |
| Q2 2020 | $42,000 | -4.5% | 1,815 | -13.3% | 0.00% | – |
| Q1 2020 | $44,000 | +158.8% | 2,093 | +184.4% | 0.00% | – |
| Q4 2019 | $17,000 | +88.9% | 736 | +67.3% | 0.00% | – |
| Q3 2019 | $9,000 | – | 440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Ten Capital Management LLC | 715,877 | $32,100,000 | 4.18% |
| Soleus Capital Management, L.P. | 430,051 | $19,283,000 | 2.49% |
| RESOURCE CONSULTING GROUP INC | 128,000 | $5,740,000 | 1.99% |
| RK Capital | 213,200 | $9,560,000 | 1.88% |
| Capital Impact Advisors, LLC | 22,797 | $1,022,000 | 0.74% |
| G2 Investment Partners Management LLC | 61,326 | $2,750,000 | 0.65% |
| EAM Investors, LLC | 76,179 | $3,416,000 | 0.64% |
| Ranger Investment Management | 193,306 | $8,668,000 | 0.55% |
| EAM Global Investors LLC | 42,885 | $1,923,000 | 0.36% |
| Hillsdale Investment Management Inc. | 121,500 | $5,448,000 | 0.35% |